Abstract
Dyspnea is a common symptom that causes considerable suffering in cancer patients. Although some knowledge of the sensory information that is transduced to the brain during dyspnea exists, we still have only a rudimentary understanding of the subjective perception of this symptom. There appear to be many parallels between pain and dyspnea. Consistent with this fact, there is growing evidence that opioids are safe and effective and should be considered front-line therapy for symptomatic relief of dyspnea. In addition to opioids, there are other important pharmacologic and nonpharmacologic tools with varying degrees of support that can be considered for symptomatic relief. Importantly, because dyspnea is a subjective symptom that occurs in a unique individual, the optimal treatment of dyspnea will always entail an understanding of, and support for, a patient’s other sources of psychosocial, spiritual, and/or existential suffering.
Similar content being viewed by others
References and Recommended Reading
Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999, 159:321–340.
Reuben DB, Mor V: Dyspnea in terminally ill cancer patients. Chest 1986, 89:234–236.
Muers MF, Round CE: Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax 1993, 48:339–343.
Higginson I, McCarthy M: Measuring symptoms in terminal cancer: are pain and dyspnoea controlled? J R Soc Med 1989, 82:264–267.
Banzett RB, Lansing RW, Reid MB, et al.: “Air hunger” arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol 1989, 76:53–67.
Lane R, Cockcroft A, Adams L, Guz A: Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci (Lond) 1987, 72:693–698.
Clark AL: Origin of symptoms in chronic heart failure. Heart 2006, 92:12–16.
Gaytan SP, Pasaro R: Connections of the rostral ventral respiratory neuronal cell group: an anterograde and retrograde tracing study in the rat. Brain Res Bull 1998, 47:625–642.
O’Donnell DE, Webb KA: Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993, 148:1351–1357.
Manning HL, Molinary EJ, Leiter JC: Effect of inspiratory flow rate on respiratory sensation and pattern of breathing. Am J Respir Crit Care Med 1995, 151:751–757.
Evans KC, Banzett RB, Adams L, et al.: BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 2002, 88:1500–1511.
Banzett RB, Mulnier HE, Murphy K, et al.: Breathlessness in humans activates insular cortex. Neuroreport 2000, 11:2117–2120.
Brannan S, Liotti M, Egan G, et al.: Neuroimaging of cerebral activations and deactivations associated with hypercapnia and hunger for air. Proc Natl Acad Sci U S A 2001, 98:2029–2034.
Liotti M, Brannan S, Egan G, et al.: Brain responses associated with consciousness of breathlessness (air hunger). Proc Natl Acad Sci U S A 2001, 98:2035–2040.
Parsons LM, Egan G, Liotti M, et al.: Neuroimaging evidence implicating cerebellum in the experience of hypercapnia and hunger for air. Proc Natl Acad Sci U S A 2001, 98:2041–2046.
Peiffer C, Poline JB, Thivard L, et al.: Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 2001, 163:951–957.
Baciu MV, Bonaz BL, Papillon E, et al.: Central processing of rectal pain: a functional MR imaging study. AJNR Am J Neuroradiol 1999, 20:1920–1924.
Binkofski F, Schnitzler A, Enck P, et al.: Somatic and limbic cortex activation in esophageal distention: a functional magnetic resonance imaging study. Ann Neurol 1998, 44:811–815.
Derbyshire SW, Jones AK, Gyulai F, et al.: Pain processing during three levels of noxious stimulation produces differential patterns of central activity. Pain 1997, 73:431–445.
Iadarola MJ, Berman KF, Zeffiro TA, et al.: Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET. Brain 1998, 121(Pt 5):931–947.
Peyron R, Garcia-Larrea L, Gregoire MC, et al.: Haemodynamic brain responses to acute pain in humans: sensory and attentional networks. Brain 1999, 122(Pt 9):1765–1780.
Denton D, Shade R, Zamarippa F, et al.: Correlation of regional cerebral blood flow and change of plasma sodium concentration during genesis and satiation of thirst. Proc Natl Acad Sci U S A 1999, 96:2532–2537.
Tataranni PA, Gautier JF, Chen K, et al.: Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci U S A 1999, 96:4569–4574.
von Leupoldt A, Mertz C, Kegat S, et al.: The impact of emotions on the sensory and affective dimension of perceived dyspnea. Psychophysiology 2006, 43:382–386.
Rainville P, Bao QV, Chretien P: Pain-related emotions modulate experimental pain perception and autonomic responses. Pain 2005, 118:306–318.
Villemure C, Bushnell MC: Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain 2002, 95:195–199.
Gracely RH, Undem BJ, Banzett RB: Cough, pain and dyspnoea: similarities and differences. Pulm Pharmacol Ther 2007, 20:433–437.
Le Bars D, Dickenson AH, Besson JM: Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 1979, 6:283–304.
Le Bars D, Dickenson AH, Besson JM: Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain 1979, 6:305–327.
Skljarevski V, Ramadan NM: The nociceptive flexion reflex in humans: review article. Pain 2002, 96:3–8.
Morelot-Panzini C, Demoule A, Straus C, et al.: Dyspnea as a noxious sensation: inspiratory threshold loading may trigger diffuse noxious inhibitory controls in humans. J Neurophysiol 2007, 97:1396–1404.
Akiyama Y, Nishimura M, Kobayashi S, et al.: Effects of naloxone on the sensation of dyspnea during acute respiratory stress in normal adults. J Appl Physiol 1993, 74:590–595.
Zebraski SE, Kochenash SM, Raffa RB: Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci 2000, 66:2221–2231.
Bruera E, MacEachern T, Ripamonti C, Hanson J: Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 1993, 119:906–907.
Chua TP, Harrington D, Ponikowski P, et al.: Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997, 29:147–152.
Williams SG, Wright DJ, Marshall P, et al.: Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 2003, 89:1085–1086.
Johnson MJ, McDonagh TA, Harkness A, et al.: Morphine for the relief of breathlessness in patients with chronic heart failure: a pilot study. Eur J Heart Fail 2002, 4:753–756.
Light RW, Muro JR, Sato RI, et al.: Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989, 139:126–133.
Abernethy AP, Currow DC, Frith P, et al.: Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003, 327:523–528.
Jennings AL, Davies AN, Higgins JP, et al.: A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002, 57:939–944.
Mazzocato C, Buclin T, Rapin CH: The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol 1999, 10:1511–1514.
Allard P, Lamontagne C, Bernard P, Tremblay C: How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage 1999, 17:256–265.
Schwartzstein RM, Lahive K, Pope A, et al.: Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987, 136:58–61.
Liss HP, Grant BJ: The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988, 137:1285–1288.
Burgess KR, Whitelaw WA: Effects of nasal cold receptors on pattern of breathing. J Appl Physiol 1988, 64:371–376.
Philip J, Gold M, Milner A, et al.: A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage 2006, 32:541–550.
Bruera E, Sweeney C, Willey J, et al.: A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliat Med 2003, 17:659–663.
Mitchell-Heggs P, Murphy K, Minty K, et al.: Diazepam in the treatment of dyspnoea in the “Pink Puffer” syndrome. Q J Med 1980, 49:9–20.
Stark RD, Gambles SA, Lewis JA: Methods to assess breathlessness in healthy subjects: a critical evaluation and application to analyse the acute effects of diazepam and promethazine on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide. Clin Sci (Lond) 1981, 61:429–439.
Woodcock AA, Gross ER, Geddes DM: Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Res Ed) 1981, 283:343–346.
Man GC, Hsu K, Sproule BJ: Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest 1986, 90:832–836.
Dudgeon DJ, Lertzman M: Dyspnea in the advanced cancer patient. J Pain Symptom Manage 1998, 16:212–219.
Navigante AH, Cerchietti LC, Castro MA, et al.: Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 2006, 31:38–47.
O’Neill PA, Morton PB, Stark RD: Chlorpromazine: a specific effect on breathlessness? Br J Clin Pharmacol 1985, 19:793–797.
Shimoyama N, Shimoyama M: Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients. J Pain Symptom Manage 2002, 23:73–76.
Nishino T, Ide T, Sudo T, Sato J: Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med 2000, 161:1963–1967.
Minowa Y, Ide T, Nishino T: Effects of inhaled furosemide on CO(2) ventilatory responsiveness in humans. Pulm Pharmacol Ther 2002, 15:363–368.
Moosavi SH, Binks AP, Lansing RW, et al.: Effect of inhaled furosemide on air hunger induced in healthy humans. Respir Physiol Neurobiol 2007, 156:1–8.
Ong KC, Kor AC, Chong WF, et al.: Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 169:1028–1033.
Sudo T, Hayashi F, Nishino T: Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats. Am J Respir Crit Care Med 2000, 162:971–975.
Taguchi O, Kikuchi Y, Hida W, et al.: Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol 1991, 71:2183–2190.
Winning AJ, Hamilton RD, Guz A: Ventilation and breathlessness on maximal exercise in patients with interstitial lung disease after local anaesthetic aerosol inhalation. Clin Sci (Lond) 1988, 74:275–281.
Wilcock A, Corcoran R, Tattersfield AE: Safety and efficacy of nebulized lignocaine in patients with cancer and breathlessness. Palliat Med 1994, 8:35–38.
Jobst K, Chen JH, McPherson K, et al.: Controlled trial of acupuncture for disabling breathlessness. Lancet 1986, 2:1416–1419.
Lewith GT, Prescott P, Davis CL: Can a standardized acupuncture technique palliate disabling breathlessness: a single-blind, placebo-controlled crossover study. Chest 2004, 125:1783–1790.
Bredin M, Corner J, Krishnasamy M, et al.: Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999, 318:901–904.
Booth S, Farquhar M, Gysels M, et al.: The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study. Palliat Support Care 2006, 4:287–293.
Nield MA, Soo Hoo GW, Roper JM, Santiago S: Efficacy of pursed-lips breathing: a breathing pattern retraining strategy for dyspnea reduction. J Cardiopulm Rehabil Prev 2007, 27:237–244.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Elia, G., Thomas, J. The symptomatic relief of dyspnea. Curr Oncol Rep 10, 319–325 (2008). https://doi.org/10.1007/s11912-008-0050-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11912-008-0050-7